Breakthrough clinical test-trials
Is Dichloroacetate a potential treatment for Endometriosis?
The Guardian, March 2023.
Groundbreaking UK Trial Tests Potential Breakthrough in Endometriosis Treatment. Scientists are working towards introducing the initial non-hormonal medication in four decades. Clinical trials for dichloroacetate show promise in alleviating intense pain in women, signaling a long-awaited breakthrough for a condition that impacts millions.
Read more
Testing Endometrial cells for new treatments
The Guardian, June 2023
Australian researchers make breakthrough discoveries through replicating endometrial cells for treatment. Researchers are cultivating endometrial tissues to study their distinct responses to treatments while observing how the cells adapt and change over time.
A deeper dive into Dichloroacetate, can it return cells to a normal metabolic function?
University of Edinburgh, 2023.
Endometriosis pain could be treated with the cancer drug dichloroacetate. Findings reveal altered cell metabolism, resembling cancer behavior. Clinical trials aim to confirm dichloroacetate’s efficacy as a non-hormonal treatment, offering hope for improved care in this under-researched condition affecting millions worldwide.
Informative research
World’s Largest Genetic Study Reveals Endometriosis is rooted in genetics.
How Endocrine disruptors can affect endometriosis.
Reproductive Toxicology, 2023
Understanding the Impact of Environmental Endocrine-Disrupting Chemicals (EDCs) on Endometriosis: A Comprehensive Review. This study delves into the role of polychlorinated biphenyls (PCBs), dioxins (TCDD), bisphenol A (BPA), and phthalates in the development and pathogenesis of this hormone condition.
An Exploration of the challenges and solutions for living with Endometriosis.
BMC’s Women’s Health, 2022
Investigating the Impact of Endometriosis: Findings from a Qualitative Study on Patients’ Struggles and Coping Mechanisms. This examination, published in BMC Women’s Health, sheds light on the challenges faced by women with endometriosis and offers insights into their self-management and coping strategies.
Possible future treatments
Is Nanotechnology a revolutionary treatment for Endometriosis Diagnosis?
Royal Society of Chemistry, October 2023.
Endometriosis, a widespread gynecological ailment affecting millions worldwide. Nanomedicine holds promise in revolutionizing its diagnosis and therapy. This review explores theranostic applications and the fusion of phototherapy with nanotech for improved endometriosis management.
Clinical efficacy, Pharmacokinetics, and the available treatments for Endometriosis-Related Pain.
MDPI, September, 2023
This review assesses drugs for endometriosis-related pelvic pain, analyzing efficacy, safety, and properties of NSAIDs, oral contraceptives, progestins, GnRH agonists/antagonists, aromatase inhibitors, and selective estrogen receptor modulators. It advocates diversified administration routes for improved management.
An updated review of reproductive Endometriosis treatments.
Reproductive and developmental medicine, 2023
A comprehensive review of current and investigational medical therapeutic options used to treat endometriosis pain, as well as a symptom-based systematic approach for patients with painful endometriosis.